Clinical Trials Directory

Trials / Completed

CompletedNCT01133314

Artemether-Lumefantrine Effectiveness in Guinea-Bissau 2

The Routine Use of Coartem for Treatment of Symptomatic Children With Plasmodium Falciparum in Bissau - 2

Status
Completed
Phase
Study type
Observational
Enrollment
600 (actual)
Sponsor
Bandim Health Project · Academic / Other
Sex
All
Age
15 Years
Healthy volunteers
Not accepted

Summary

The routine treatment of children with antimalarials will be monitored. Children with a positive malaria film and/or a positive rapid diagnostic test (RDT) will have a capillary blood sample taken to verify the diagnosis and to monitor the pattern of resistance.

Detailed description

Children from Bissau seeking medical advice and who are recommended treatment for malaria in accordance with the current routines will be included as follows: All children getting the clinical diagnosis of malaria will be registered and basic information collected. All children with a positive malaria film and/or a positive RDT will be asked for a capillary blood sample (app. 50 - 100 microliters on a filterpaper). Using PCR the parasitological diagnosis will be verified and if parasites are identified the resistance patterns will be examined. Both the capillary blood samples and the RDTs (if taken by the health staff) will be used in order to examine whether the RDTs can be used for routine monitoring of resistance in an area. The study does not interfere in the routine treatment of the health staff. None of the children will be followed.

Conditions

Timeline

Start date
2010-05-01
Primary completion
2012-12-01
Completion
2016-07-01
First posted
2010-05-28
Last updated
2021-05-26

Locations

1 site across 1 country: Guinea-Bissau

Source: ClinicalTrials.gov record NCT01133314. Inclusion in this directory is not an endorsement.